Spinal injury study seeks to unlock vaccine secrets
NCT ID NCT05869968
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares immune responses to flu and COVID-19 vaccines between people with chronic spinal cord injuries and healthy individuals. Researchers will analyze blood samples to see if gene activity and antibody levels differ between the groups. The goal is to understand why people with spinal cord injuries face higher infection risks and how vaccines can work better for them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal why people with spinal cord injuries are more prone to infections and how to better protect them through vaccines.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve health, and results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 VACCINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwell Health
Manhasset, New York, 11030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could music be medicine for the injured brain?
- Robots join the rehab team: a new hope for regaining movement?
- Can a sugar pill curb the opioid crisis?
- Testosterone may rebuild strength after spinal cord injury — trial puts it to the test
- Can a smart brain implant outsmart chronic pain?
- Mining mountains of data to outsmart diabetes complications